The goal of this clinical trial is to evaluate the feasibility, acceptability, and preliminary efficacy of mindfulness-based interventions (MBI) as a vaping cessation intervention in young adults aged 18-29 who vape nicotine at least 25 days per month and are interested in cutting down or quitting. The main questions it aims to answer are:

• Can mindfulness practice reduce nicotine cravings in young adults?
• Is mindfulness practice an acceptable and feasible intervention for vaping cessation in this population?

Researchers will compare participants in the mindfulness intervention group to a control group that watches a video with calming music and images to see if mindfulness practice has a greater effect on reducing nicotine cravings.

Participants will:

• Complete a baseline survey and craving cue reactivity assessment.
• Engage in a 10-minute guided mindfulness meditation (intervention group) or view calming music and images (control group).
• Rate their cravings and the acceptability, appropriateness, and feasibility of the intervention after the session.

Inclusion Criteria:

• Young adults aged 18-29 years old
• Residing in the United States
• Able to read and speak English
• Vape nicotine at least 25 days/month,
• Interested in cutting down or quitting vaping in the next 30 days (rated at least a 5 on a 10-point scale).

Exclusion Criteria:

• Using any nicotine-containing products other than e-cigarettes
• A current or past Diagnostic and Statistical Manual of Mental Disorders (DSM-5) psychiatric diagnosis of severe mental illness
• A current DSM diagnosis of substance use disorders other than tobacco use disorder
• Involved in regular mindful practice
• Undergoing current smoking/vaping cessation treatment (counseling and/or medication)
• Taking any medications that may potentially affect nicotine craving, consumption, or mood within the past 30 days.